14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Tue, 7 May 2024

ZYNE Predictions History

6 years ago
JS predicted that ZYNE for 2017-07-05 is going $16.81 (-0.53%)

6 years ago
David predicted that ZYNE for 2017-07-05 is going $24.12 (42.72%)

Rank:

6 years ago
bbullish2 predicted that ZYNE for 2017-07-05 is going $17.97 (6.33%)

7 years ago
JS predicted that ZYNE for 2017-04-27 is going $21.40 (1.95%)

7 years ago
JuanC Villegas predicted that ZYNE for 2017-04-27 is going $21.45 (2.34%)

7 years ago
Carlos.Manosalva.5612 predicted that ZYNE for 2017-04-17 is going $22.00 (-12.66%)

Rank:

7 years ago
JS predicted that ZYNE for 2017-04-11 is going $24.31 (-1.58%)

7 years ago
PeteKTF predicted that ZYNE for 2017-02-03 is going $18.60 (4.03%)

7 years ago
PeteKTF predicted that ZYNE for 2017-02-02 is going $19.00 (5.38%)

7 years ago
Raven predicted that ZYNE for 2017-01-12 is going $21.57 (12.87%)

Rank:
Click to get the best stock tips daily for free!

About Zynerba Pharmaceuticals

Zynerba Pharmaceuticals Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for transdermal delivery. The company was formerly known as AllTranz, Inc. and changed its name to Zynerba P... ZYNE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT